Physician profile
Killian Norton
NPI 1962057836
$1,154.73
in general payments reported to CMS, 2019-2025
20 companies · $21.75 in 2025
The $21.75 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $374 · 2023: $665 · 2024: $94.27 · 2025: $21.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208.16 | 2022-2025 | |
| Novo Nordisk INC | $151.67 | 2022-2023 | Ozempic, Rybelsus |
| Mylan Specialty L.P. | $98.33 | 2022-2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $79.33 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $66.27 | 2022-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $64.25 | 2023 | Verquvo, Dificid, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.82 | 2022-2023 | |
| Pfizer INC. | $62.47 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $53.97 | 2022-2023 | |
| Amgen INC. | $51.77 | 2022-2023 | Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $44.31 | 2023 | Gvoke Hypopen |
| Lilly USA, LLC | $40.11 | 2022 | |
| Dexcom, INC. | $39.27 | 2022-2023 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $35.04 | 2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Edwards Lifesciences Corporation | $24.91 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $18.44 | 2023 | |
| Medtronic, INC. | $16.83 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.92 | 2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $11.92 | 2022 | |
| Corium, LLC | $9.94 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Killian Norton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.